Download this Paper Open PDF in Browser

The Application of EU Competition Law in the Pharmaceutical Sector: The Case of Parallel Trade

64 Pages Posted: 25 Jan 2013 Last revised: 7 Aug 2017

Lazaros Grigorios Grigoriadis

Aristotle University of Thessaloniki; Neapolis University Pafos (Cyprus)

Date Written: January 24, 2013

Abstract

Parallel trade traditionally enjoys a significant protection from European Institutions, in the belief that it fosters competition and encourages trade. However, pharmaceutical companies claim that this form of competition undermines their incentive to innovate and threatens the competitiveness of the European pharmaceutical sector. This Article analyses a) the arguments put forward in favour of and against the freedom of parallel trade of pharmaceuticals between the EU Member States and b) the case-law relating to parallel trade of pharmaceuticals developed by the EU courts and more specifically by the Court of Justice (“CJ”) (former Court Justice of the European Communities/“ECJ”)and by the General Court (“GC”) (former Court of First Instance of the European Communities/“CFI”) in the light of the EU competition law (Articles 101-102 of the TFEU).

Keywords: Competition, EU Law, Pharmaceuticals, Parallel Trade

JEL Classification: L4, K21, K33

Suggested Citation

Grigoriadis, Lazaros Grigorios, The Application of EU Competition Law in the Pharmaceutical Sector: The Case of Parallel Trade (January 24, 2013). European Business Law Review, Vol. 25, No. 1, 2014, pp. 141-201. Available at SSRN: https://ssrn.com/abstract=2206244

Lazaros Grigorios Grigoriadis (Contact Author)

Aristotle University of Thessaloniki ( email )

No Address Available
00306948148445 (Phone)

Neapolis University Pafos (Cyprus) ( email )

2 Danais Avenue
Pafos, 8042
Cyprus

Paper statistics

Downloads
5
Abstract Views
1,200